Lipocine Inc — Dividend History & Yield (NASDAQ:LPCN) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

ニュース

Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates

Lipocine completes patient visits in phase 3 trial for PPD treatment

H.C.ワインライト、リポシン社の株価目標を臨床試験進捗により15ドルに引き上げ

H.C. Wainwright raises Lipocine stock price target to $15 on PPD trial progress

Lipocine completes enrollment in phase 3 trial for PPD treatment

リポシン社のPPD薬臨床試験、安全性評価で継続決定

Lipocine’s PPD drug trial continues after positive safety review

リポシン、産後うつ薬の治験で80%の登録を達成

Lipocine reaches 80% enrollment in postpartum depression drug trial

リポシン、年次AES会議でてんかん候補薬LPCN 2101のデータを発表

Lipocine presents LPCN 2101 epilepsy candidate data at annual AES meeting

リポシン、産後うつ治療薬の第3相試験で肯定的な安全性評価を報告